BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33119213)

  • 21. Direct next-generation sequencing analysis using endometrial liquid-based cytology specimens for rapid cancer genomic profiling.
    Akahane T; Kitazono I; Kobayashi Y; Nishida-Kirita Y; Yamaguchi T; Yanazume S; Tabata K; Kobayashi H; Tanimoto A
    Diagn Cytopathol; 2021 Sep; 49(9):1078-1085. PubMed ID: 34319014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving Adequacy of Small Biopsy and Fine-Needle Aspiration Specimens for Molecular Testing by Next-Generation Sequencing in Patients With Lung Cancer: A Quality Improvement Study at Dartmouth-Hitchcock Medical Center.
    Padmanabhan V; Steinmetz HB; Rizzo EJ; Erskine AJ; Fairbank TL; de Abreu FB; Tsongalis GJ; Tafe LJ
    Arch Pathol Lab Med; 2017 Mar; 141(3):402-409. PubMed ID: 27763790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Next-generation sequencing in residual liquid-based cytology specimens for cancer genome analysis.
    Yamaguchi T; Akahane T; Harada O; Kato Y; Aimono E; Takei H; Tasaki T; Noguchi H; Nishihara H; Kamata H; Tanimoto A
    Diagn Cytopathol; 2020 Nov; 48(11):965-971. PubMed ID: 32511899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using "residual" FNA rinse and body fluid specimens for next-generation sequencing: An institutional experience.
    Wei S; Lieberman D; Morrissette JJ; Baloch ZW; Roth DB; McGrath C
    Cancer Cytopathol; 2016 May; 124(5):324-9. PubMed ID: 26682952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of next-generation sequencing on small tumor specimens and/or low tumor content samples using a commercially available platform.
    Morris SM; Subramanian J; Gel ES; Runger GC; Thompson EJ; Mallery DW; Weiss GJ
    PLoS One; 2018; 13(4):e0196556. PubMed ID: 29702695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytology smears for DNA extraction: Practical approach for selecting the best slide.
    Gupta N; Brenkert R; Lee JW; Klein M; Spitzer S; Chau K; Das K
    Cytopathology; 2019 Jan; 30(1):68-73. PubMed ID: 30055110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poor cell block adequacy rate for molecular testing improved with the addition of Diff-Quik-stained smears: Need for better cell block processing.
    Harada S; Agosto-Arroyo E; Levesque JA; Alston E; Janowski KM; Coshatt GM; Eltoum IA
    Cancer Cytopathol; 2015 Aug; 123(8):480-7. PubMed ID: 25955105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diff-Quik Cytology Smears from Endobronchial Ultrasound Transbronchial Needle Aspiration Lymph Node Specimens as a Source of DNA for Next-Generation Sequencing Instead of Cell Blocks.
    Fielding D; Dalley AJ; Bashirzadeh F; Singh M; Nandakumar L; McCart Reed AE; Black D; Kazakoff S; Pearson JV; Nones K; Waddell N; Lakhani SR; Simpson PT
    Respiration; 2019; 97(6):525-539. PubMed ID: 30731462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples?
    Bellevicine C; Sgariglia R; Malapelle U; Vigliar E; Nacchio M; Ciancia G; Eszlinger M; Paschke R; Troncone G
    Cancer Cytopathol; 2016 Nov; 124(11):776-784. PubMed ID: 27717198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular testing of cytology specimens: Issues in specimen adequacy and clinical utility.
    Ghous G; Ijaz K; Esebua M; Layfield LJ
    Diagn Cytopathol; 2024 Feb; 52(2):123-130. PubMed ID: 38017653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive Genomic Profiling of Malignant Effusions in Patients with Metastatic Lung Adenocarcinoma.
    Yang SR; Lin CY; Stehr H; Long SR; Kong CS; Berry GJ; Zehnder JL; Kunder CA
    J Mol Diagn; 2018 Mar; 20(2):184-194. PubMed ID: 29269277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted deep sequencing of effusion cytology samples is feasible, informs spatiotemporal tumor evolution, and has clinical and diagnostic utility.
    Leichsenring J; Volckmar AL; Kirchner M; Kazdal D; Kriegsmann M; Stögbauer F; Bockmayr T; Klauschen F; Herth FJF; Penzel R; Warth A; Schirmacher P; Endris V; Stenzinger A
    Genes Chromosomes Cancer; 2018 Feb; 57(2):70-79. PubMed ID: 29044880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent fine needle aspirations and core needle biopsies: a comparative study of substrates for next-generation sequencing in solid organ malignancies.
    Roy-Chowdhuri S; Chen H; Singh RR; Krishnamurthy S; Patel KP; Routbort MJ; Manekia J; Barkoh BA; Yao H; Sabir S; Broaddus RR; Medeiros LJ; Staerkel G; Stewart J; Luthra R
    Mod Pathol; 2017 Apr; 30(4):499-508. PubMed ID: 28084342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NTRK testing: First results of the QuiP-EQA scheme and a comprehensive map of NTRK fusion variants and their diagnostic coverage by targeted RNA-based NGS assays.
    Kirchner M; Glade J; Lehmann U; Merkelbach-Bruse S; Hummel M; Lehmann A; Trautmann M; Kumbrink J; Jung A; Dietmaier W; Endris V; Kazdal D; Ploeger C; Evert M; Horst D; Kreipe H; Kirchner T; Wardelmann E; Büttner R; Weichert W; Dietel M; Schirmacher P; Stenzinger A; Pfarr N
    Genes Chromosomes Cancer; 2020 Aug; 59(8):445-453. PubMed ID: 32319699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiplatform comparison of molecular oncology tests performed on cytology specimens and formalin-fixed, paraffin-embedded tissue.
    Gailey MP; Stence AA; Jensen CS; Ma D
    Cancer Cytopathol; 2015 Jan; 123(1):30-9. PubMed ID: 25186473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Invited review-next-generation sequencing: a modern tool in cytopathology.
    Roy-Chowdhuri S; Pisapia P; Salto-Tellez M; Savic S; Nacchio M; de Biase D; Tallini G; Troncone G; Schmitt F
    Virchows Arch; 2019 Jul; 475(1):3-11. PubMed ID: 30877381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utilization of cytologic cell blocks for targeted sequencing of solid tumors.
    Vormittag-Nocito E; Kumar R; Narayan KD; Chen Z; David O; Behm F; Mohapatra G
    Cancer Med; 2023 Feb; 12(4):4042-4063. PubMed ID: 36125633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of a 50-gene next generation sequencing panel with post-centrifuge supernatant cytology fluid in non-small-cell lung cancer.
    Tafoya M; Judd A; Chiotti K; Dearen K; Jiron K; Chabot-Richards D; Broehm CJ
    Diagn Cytopathol; 2021 Nov; 49(11):1173-1178. PubMed ID: 34339108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous detection of single-nucleotide variant, deletion/insertion, and fusion in lung and thyroid carcinoma using cytology specimen and an RNA-based next-generation sequencing assay.
    Guseva NV; Jaber O; Stence AA; Sompallae K; Bashir A; Sompallae R; Bossler AD; Jensen CS; Ma D
    Cancer Cytopathol; 2018 Mar; 126(3):158-169. PubMed ID: 29364576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of recurrent, rare, and novel gene fusions in patients with acute leukemia using next-generation sequencing approaches.
    Kim B; Kim E; Lee ST; Cheong JW; Lyu CJ; Min YH; Choi JR
    Hematol Oncol; 2020 Feb; 38(1):82-88. PubMed ID: 31875988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.